In this study, we found that TBMS1 treatment lowered VEC expression of cancer adhesion molecules (ICAM-1 and VCAM-1), and reduced cancer cells adhesion on VEC monolayers (Figure 5). The gene discussed is ICAM1; the disease is cancer.